期刊文献+

替比夫定(telbivudine) 被引量:12

下载PDF
导出
作者 刘晓东 胡春
机构地区 中国医科大学
出处 《中国药物化学杂志》 CAS CSCD 2007年第5期335-335,共1页 Chinese Journal of Medicinal Chemistry
  • 相关文献

参考文献4

  • 1LAURA A.FDA approves new treatment for chronic hepatitis B in adults[EB/OL].[2006-10-25].http://www.fda.gov/bbs/topics/NEWS/2006/NEW01498.html.
  • 2STORER R,MOSSA A,WANG J Y,et al.Synthesis of β-L-2-deoxy-nucleosides:WO,2005/003374[P].2005-01-13.
  • 3Novsrtis.Tyzeka tablets[EB/OL].[2006-10-25].www.pharma.us.novartis.com/product/pi/pdf/tyzeka.pdf.
  • 4许洁,陆志檬.替比夫定治疗慢性乙型肝炎的进展[J].中华肝脏病杂志,2006,14(12):958-959. 被引量:37

二级参考文献14

  • 1Bryant ML,Bridges EG,Placidi L,et al.Antiviral L-nucleosides specific for hepatitis B virus infection.Antimicrob Agents Chemother,2001,45:229-235.
  • 2Zhou XJ,Lloyd DM,Cbao GC,et al.Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects.J Clin Pharmacol,2006,46:275-281.
  • 3Zhou XJ,Lim SG,Lloyd DM,et al.Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection:pharmacodynamic implications.Antimicrob Agents Chemother,2006,50:874-879.
  • 4Lai,CL,Lim SG.A dose finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.Hepatology,2004,40:719-726.
  • 5Lai CL,Leung N,Teo EK,et al.A l-year trial of telbivudine,lamivudine,and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.Gastroenterology,2005,129:528-536.
  • 6Lai CL,Leung N,Teo EK,et al.Phase Ⅱb Extended-Treatment Trial of Telbivudine (LdT) vs.Lamivudine vs Combination Treatment in Hepatitis B Patients:Two-Year Results.DDW,Chicago,IL,USA.2005.
  • 7Lai CL,Gane E,Thongsawat S,et al.Telbivudine (LdT) vs.Lamivudine in the treatment of Chronic Hepatitis B:Results from GLOBE,an international Phase Ⅲ TriaL.Shanghai-Hong Kong International Liver Congress; 2006.
  • 8Lai CL,Gane E,Hsu CW,et al.Two-Year Results from the GLOBE Trial in Patients with Hepatitis B:Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine.Hepatology,2006,44(4 Suppl 1):222A.
  • 9Hou JL,Yin YK,Xu DZ,et al.A phase Ⅲ comparative trial of telbivudine and lamivudine for treatment of chronic hepatitis B in Chinese patients:first year results.Presented at:Shanghai-Hong Kong International Liver Congress; 2006.
  • 10Bzowej N,Chan LYH,Lai CL,et al.A randomized trial of telbivudine(LdT) vs.adefovir for HBeAg-positive chronic hepatitis B:final week52 results.Hepatology,2006,44(4,Suppl 1):563A.

共引文献36

同被引文献83

引证文献12

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部